Jump to content
Objectivism Online Forum


  • Content Count

  • Joined

  • Last visited

  • Days Won


happiness last won the day on March 23

happiness had the most liked content!

1 Follower

About happiness

  • Rank

Previous Fields

  • Country
    United States
  • State (US/Canadian)
  • Relationship status
  • Copyright

Recent Profile Visitors

4454 profile views
  1. A female co worker (who was formerly my trainer) five years my senior has been flirting with me on the job since day one. At first, I took it as joke and blew her off, but I’ve noticed she doesn't seem to do it with the other guys there, and lately she's been ramping it up...by doing stuff like rubbing my back, grabbing my leg, and slipping in a few overtly sexual comments. Though I feign disinterest, I secretly like it and am attracted to her even though I’m pretty sure she’s a different walk of life and not a long-term match for me. I’m aware of the adage “don’t shit where you eat,” but is it really that wise? Hank and Dagny were co-workers, right?
  2. Maybe this country still has a sliver of decency, but the people who oppose this don’t. The HillHouse passes 'right to try' drug billBY RACHEL ROUBEIN - 03/21/18 The House passed “right to try” legislation on experimental drugs largely along party lines Wednesday, sending a bill backed by President Trump to the Senate.Last week, House Republican leaders put the bill on the floor under suspension of the rules. Democrats objected, expressing safety concerns over how the measure would bypass the Food and Drug Administration, and it fell short of the necessary two-thirds support it needed.But leaders made clear the House would take up the bill again. On the second try, the House only needed a simple majority to pass the bill, and easily did so in the 267 to 149 vote.Thirty-five Democrats voted for the bill, and two Republicans opposed it. Now, the measure goes to the Senate, where a version of the bill passed in August by unanimous consent.Sen. Ron Johnson (R-Wis.), who has championed the bill in the Senate, urged his chamber to quickly pass the measure. “Right to try needs to become the law of the land. It passed the Senate unanimously last summer, and I’m disappointed the House didn’t pass that bill and send it to the president for his signature," Johnson said in a statement."Nonetheless, I plan to ask my colleagues to pass right to try again immediately. Terminally ill patients and their families have waited long enough.”House Republicans revised the bill amid objections from some supporters who had hoped the Senate version would pass, wanting to prevent the measure from ping-ponging between the two chambers. They worried that could make it harder to get the bill to Trump’s desk.The bill lets terminally ill patients request access to drugs the FDA hasn’t yet approved without going through the agency. Patients can request the drugs from manufacturers if the medicine has gone through a small-scale clinical trial and is still under FDA consideration.Though no senators objected to the bill, the legislation — which had been revised — proved controversial in the House.Democrats there, as well as more than 75 patient advocacy groups, have voiced several different concerns, and patient safety was chief among them.“By allowing patients access to investigational treatments that have only completed a phase 1 clinical trial, patients will be exposed to treatments with no or relatively little data that they are actually effective,” the top Democrat on the House Energy and Commerce Committee, Rep. Frank Pallone Jr. (N.J.), said during the debate on the House floor Wednesday.“These extremely small trials only examine the safety and toxicity of a drug and do not determine the effectiveness or potential side effects.”Opponents of the bill also point to the FDA’s compassionate use program, saying the agency approves 99 percent of requests to let a patient use an experimental drug. They argue the legislation provides “false hope,” as drug manufacturers aren’t required to provide the drug to patients who ask.But House Energy and Commerce Chairman Greg Walden (R-Ore.) and health subcommittee chairman Rep. Michael Burgess (R-Texas) maintained that their version of the bill struck “the right balance for patients and their safety.”Supporters of the measure have argued that people with a terminal illness should have every tool at their disposal to try a drug that could possibly help them.Rep. Morgan Griffith (R-Va.) said that if faced with a terminal illness, he’d “take any risk, including injecting monkey urine if that meant I could spend a few more days, months or years with my children.”Proponents of the legislation have also argued that the drug approval process takes too long, and that the bill isn't unsafe, as medicines must have passed a phase 1 clinical trial and still be in FDA’s pipeline.The legislation has powerful backers.President Trump has urged Congress to pass the bill, notably in his State of the Union address in late January. Vice President Pence is a staunch supporter of right to try, signing the bill into law when he was governor of Indiana. And groups backed by conservative mega-donors Charles and David Koch have also been pushing for its passage.
  3. Had a couple of super uncomfortable encounters today. While on a bike ride I ran into a guy who was a close friend for a very long time, but whom I haven’t seen or talked to much in the last five years. He’s a successful insurance agent now, which I respect, but has taken to getting involved in local politics (I believe) as a form of marketing, which I’m not so impressed with. He’s a leader in a local organization that campaigns for school bonds and posts a bunch boring stuff about it on FB. During our brief convo, he mentioned the school levy coming up and casually “reminded” me to support it. Not wanting to disagree, I said something like “cool, OK, I’ll do that” and changed the subject by saying hi to his young son. I so dreaded the awkwardness that disagreeing with him would cause that I lied to avoid it. Less than an hour later, a woman from his organization came to my door and asked if she could count on my support. I politely told her that I disagree with the measure and to have a good rest of her day, to which she replied condescendingly, “you disagree with making our schools safer?” Lol. At that point someone else came to the door and I let that person talk to her. This is a gated community where homeowners pay dues to keep solicitors out—I suspect my friend used his connections to the HOA to get permission for the organization to campaign here. If so, not cool. Anyway, how spineless was I to imply that I would support my childhood friend’s cause? What would you say instead? “I don’t believe in public education, but since it will probably pass I hope the kids benefit from it?” Ugh better but still so cringeworthy. I want to be able to disagree respectfully and shut it down without burning a friend. You can tell I don’t have much experience in these situations. I’ve always lived by a strict “no politics” policy in social situations unless I know I’m talking to someone who agrees with me.
  4. Cold-blooded murderers, every last one of them. https://www.google.com/amp/amp.washingtontimes.com/news/2018/mar/13/house-democrats-block-patients-right-try-bill/
  5. There is a very grassroots group that advocates for the cause and is a mix of good and bad. The leadership doesn’t have much of a grasp of how to argue, puts out poorly edited articles and social media content, and sometimes lives up to the other side's characterizion of patients as being easily misled. They blew me away last year by spearheading the Texas law that passed, which will be a game-changer if federal authorities don't interfere, so I have to give them some credit.
  6. As Nicky noted, the proprietary Regenexx procedure is approved in the Cayman Islands, where the regulations are less stringent than in the US (I had 20+ joints treated at the Cayman clinic last year with good results). Cultured stem cell treatments in general aren’t freely practicable anywhere to my knowledge, but are still performed in certain places throughout the world either through specials favors from local governments or where their legal status is uncertain. Japan also recently passed a law that significantly deregulates stem cell “drugs,” allowing them to skip phase-3 clinical trials (the most burdensome part of the approval process).
  7. Statutorily, a preparation of cells qualifies as “drug” subject to FDA regulation if the cells are “more than minimally manipulated.” The specific treatment I need calls for a patient's stem cells to be isolated from his bone marrow and culture-expanded to grow them to multiplicity. The expanded cells are then implanted into an arthritic joint, where, if the process is performed by skilled hands, they are well-documented to be capable of exerting reparative effects. In 2010, the FDA sued the company that pioneered this procedure on the grounds that the expanded cells are "more than minimally manipulated" (see ARI's commentary). The FDA prevailed, and it is now illegal for any doctor to administer culture-expanded stem cells in the US without obtaining a biologics license, the cost of which is so burdensome that it renders the procedure economically unviable in today’s regulatory environment. The cause also seems obstructed by parties with serious conflicts of interest. The former FDA commissioner said this: “When I was commissioner of the Food and Drug Administration (FDA) from 2005 to 2009, I saw firsthand how regenerative medicine offered a cure for kidney and heart failure and other chronic conditions like diabetes. Researchers used stem cells to grow cells and tissues to replace failing organs, eliminating the need for expensive supportive treatments like dialysis and organ transplants… For example, in August 2010, the FDA filed suit against a company called Regenerative Sciences. Three years earlier, the company had begun marketing a process it called Regenexx to repair damaged joints by injecting them with a patient’s own stem cells. The FDA alleged that the cells the firm used had been manipulated to the point that they should be regulated as drugs. A resulting court injunction halting use of the technique has cast a pall over the future of regenerative medicine.“ I don’t think it’s unreasonable to project that, by the end of the ensuing decade, the FDA vs. Regenerative Sciences decision will probably have resulted in millions of preventable deaths.
  8. I have Google alerts set up to send me articles on regulatory policy pertaining to adult stem cell therapy. While not a popular issue, there is a battle raging on among interested parties on the internet, in the media, and in the legislatures, where there have been a few credible attempts at deregulation. The odds have always been stacked against patient freedom, and the progress has mostly reflected that, but there have been a few positive developments, most notably a Texas law that makes federally prohibited adult stem cell therapies legal at the state level starting in the near future—it remains to be seen whether the FDA will interfere. In the last two years there has also been an explosion of clinics offering a legal kind of stem cell treatment that doesn't meet the FDA's ever-changing definition of a "drug," and this has provoked much negative press, always outrageously biased and clearly intended to fearmonger, spread misinformation, and drum up public support for regulators to stamp these treatments out of existence. So, I have to stay abreast of what's happening on the regulatory front since it has such important implications for me. I wish it was easy to set it aside when I'm done processing the latest news.
  9. no more* dismissive
  10. It’s crazy that I’ve been following Peter Schiff for 10 years and his predicted economic collapse hasn’t played out, yet all along I’ve felt as if the threat has been imminent, and even hoarded a small fortune (by my standards) in gold. I’m actually no less dismissive of the collapse scenario than I’ve ever been, and still holding tightly to my gold, but at this point I do at least grant the possibility that the Schiffs of the world could turn out to be completely wrong. If this is the case, what flaws in my general thinking could have contributed to the formation of this erroneous belief that, five years ago, I held with certainlty? Over-pessimism? Some degree of emotionalism? Lack of understanding of economics? Maybe just being out of my depth?
  11. Thanks. I haven’t take taken anything stated here as snide, though.
  12. With the Govt spying, there are many reasons you can’t be assured it’s safe to do this. I’m not sure that America comparing favorably to other counties means much, as the rest of the world sets the bar pretty low. Status quo FDA policy is morally equivalent to the mass murder of sick people. Regardless of how it’s rationalized, cutting off a person’s access to a needed medicine is no different than slaughtering him by any other means. I don’t know what percentage of voters have any awareness of this issue, but the overwhelmingly negative response to the Right to Try bill I’ve observed shows that the majority of people who understand what the FDA does are clearly apologists for mass murder. That’s pretty evil. I’m not terminally ill, so this bill doesn’t affect me, but I’m in the same boat with a chronic disease which is highly treatable with an advanced therapy that the FDA will probably never let happen in US, so the issue is deeply personal to me. I’ve tried to deal with the issue constructively by presenting the pro-freedom side wherever I could, but found that pretty much every time I’ve either been downvoted into oblivion or treated to the most banal displays of irrationality one could ever hope to come across. The other side’s arguments always follow same pattern: they focus solely on the possibility of harm caused by unregulated medicines, cherry-pick the negative as evidence, treat the priestly bureaucrats as omniscient and incorruptible without any justification and against all evidence to the contrary, and use inane buzzwords like “snake oil” as substitutes for facts. I have argued with MDs who ardently support the FDA and never seen anyone muster anything more intelligent than “BUT BUT BUT THALIDOMIDE!!!” Trying go educate others on this is simply a gigantic waste of time. So what are my options? Try to find a more effective way to communicate the issue even though the prospect of positive change anytime soon seems impossible. Avoid debate and try to block out current events. Focus on my life and generating enough funds for more offshore treatments. Say the Hell with it all, it’s been fun. Most of the time I’m in mode #2, but sometimes read an article like the one I posted, and my blood just boils over.
  13. Is there a reason it would be less likely to pass the House when it’s already passed the Senate? If it passes the House it’s as good as law.
  14. I cannot stand that I live in a country where the majority of people even tolerate these views , much less one where biggest media outlets and allegedly scientific publications promote this utter filth as the voice of science and reason. All the "Right to Try" legislation does is is give people a chance to live when they have no other chance, and only after the drugs have passed the phase of testing that allegedly proves safety. What kind of foaming-at-the mouth animal would oppose that? Physicians, ethicists urge Congress not to pass ‘right-to-try’ legislation Science Feb 3, 2018 4:15 PM EST WASHINGTON — Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health. The letter was drafted by Alison Bateman-House, associate professor of medical ethics at NYU Langone Health, along with some of her colleagues. It is addressed to the leaders of the House Committee on Energy and Commerce, the committee currently considering a so-called “right-to-try” bill. The letter was circulated for online signatures on Thursday, and organizers said they planned to send the letter on Feb. 5. In August the Senate passed a right-to-try bill sponsored by Sen. Ron Johnson, which is now sitting in a House committee. The bill would allow patients with life-threatening conditions access to drugs that have not been approved by the Food and Drug Administration. FDA Commissioner Scott Gottlieb has expressed reservations about the bill, but President Trump seems to support it. The 40-plus signatories of the draft letter, however, say they are strongly opposed. “This legislation sells vulnerable patients and families false hope at the expense of weakening the FDA’s critical role in making sure that all Americans can have confidence in the safety and effectiveness of our medical products,” the draft letter read on Thursday afternoon. The FDA already has a pathway for patients to be able to use experimental treatments outside of clinical trials, which is called “expanded access” or “compassionate use.” According to an FDA study, 99 percent of requests made from 2005 to 2014 for these experimental drugs were approved. But a right-to-try bill would allow doctors and patients to skirt around the FDA, leaving them more vulnerable if something goes wrong. “Patients with terminal conditions who access unapproved therapies outside of clinical trials may be at risk of hastened death or reduced quality of the life that they have left, and deserve protections similar to patients taking part in clinical trials,” the authors wrote. Andrew Powaleny, a spokesperson for the pharmaceutical industry organization PhRMA, which hasn’t taken a firm stance on the legislation, said, “It is crucial that any right-to-try policy proposals protect patient safety and the integrity of the clinical trial process along with U.S. Food and Drug Administration oversight. PhRMA appreciated the opportunity last fall to work with Sen. Johnson on his proposal and is engaged in an ongoing dialogue with his office and Energy and Commerce Committee Chairman Walden.” Trump doubles down Meanwhile, in a speech to Republican lawmakers on Thursday, Trump reiterated his support for congressional action on the subject. He first spokepublicly in favor of right-to-try legislation in his State of the Union address on Tuesday. “I hope you folks can approve it, and I hope you agree with it,” Trump told Republican members of Congress at a Thursday retreat in Greenbrier, West Virginia. Trump’s remarks implied that FDA Commissioner Scott Gottlieb was on his side, saying that Gottlieb was “heading it up.” However, Gottlieb has actually expressed concern about the current bill that the House is considering, testifying at an October hearing that it would undercut the agency’s authority to protect patients from unsafe drugs. The FDA declined to comment Thursday. Bateman-House testified at the October hearing alongside Gottlieb. She said that she has not been in touch with the committee since the hearing, and that she thought after the hearing the bill had “more or less died.” But Vice President Pence has been vocal recently on the issue, proclaiming his support in January. He signed a similar bill in Indiana as governor in 2015. Thirty-eight states now have such laws. “I think his heart’s probably in the right place,” Bateman-House said of Pence. “I just wish he would put all this time and energy [into legislation] that was actually going to help patients.” This article is reproduced with permission from STAT. It was first published on Feb. 1, 2018. Find the original story here.
  15. I'm not sure how I would define rudeness exactly, but it is a type of communication that could justifiably offend and cause emotional distress. Say you're calling a customer service line with a legitimate reason to be angry—is it OK to yell at the person and use expletives? Or is this kind of conduct always gratuitous?